Interestingly, the genetic polymorphism in OGG1 (Ser[326]Cys) has been associated with T2D risk in MAs26 further suggesting that insufficient response to oxidative DNA damage may be implicated in metabolic disease in the MA population. The gene discussed is OGG1; the disease is Other metabolic disease.